Condition: Bladder (Urothelial, Transitional Cell) Cancer · Kidney (Renal Cell) Cancer · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Bladder and kidney cancers are commonly diagnosed in older adults. Surgery remains the primary treatment modality for patients with kidney or bladder cancer. In older patients, common co-morbidities include fatigue, physical deconditioning characterized by reduced cardiorespiratory fitness and progressing sarcopenia, pain- whether disease- related or treatment-induced- and undernutrition. These factors increased the risk of post-operative complications and exacerbate patient frailty. The investigators propose a personalized 6-month program both pre- and post-surgery, including adapted physical activity sessions, therapeutic education workshops, and systematic referral to the department's DAPAP program.
This description comes directly from the study's public registry record.
Evolène FAYOLLE, student · (0)4 77 12 78 35 · evolene.fayolle@chu-st-etienne.fr
Amandine BAUDOT, Project Manager · (0)4 77 82 94 50 · amandine.baudot@chu-st-etienne.fr
Always discuss trial participation with your own doctor first.
| Chu Saint-Etienne | Saint-Etienne, France | Recruiting |
| Hôpital privé de la Loire | Saint-Etienne, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07073703